Gavin MacBeath
Directeur Général chez TSCAN THERAPEUTICS, INC.
Fortune : 362 801 $ au 30/04/2024
Profil
Dr. Gavin MacBeath is a Chief Executive Officer & Director at TScan Therapeutics, Inc. He is on the Board of Directors at TScan Therapeutics, Inc. Dr. MacBeath was previously employed as a Chief Scientific Officer by Abpro Corp., an Associate Professor by Harvard University, and a Senior Director & Head-Translational Rese by Merrimack Pharmaceuticals, Inc. He received his undergraduate degree from the University of Manitoba and a doctorate degree from The Scripps Research Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0,11% | 31/03/2024 | 49 767 ( 0,11% ) | 362 801 $ | 30/04/2024 |
Postes actifs de Gavin MacBeath
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur Général | 28/03/2023 |
Anciens postes connus de Gavin MacBeath
| Sociétés | Poste | Fin |
|---|---|---|
| ABPRO CORPORATION | Directeur Technique/Scientifique/R&D | 01/07/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Fondateur | 01/09/2017 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2010 |
Formation de Gavin MacBeath
| University of Manitoba | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
